Cladribine: not just another purine analogue? - Wikidata - wikimedia - TriplyDB

Cladribine: not just another purine analogue?

Cladribine: not just another purine analogue?

http://www.wikidata.org/entity/Q34992373

about

Methotrexate and Pralatrexate Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats The cladribine conundrum: deciphering the drug's mechanism of action.Emerging therapies for treatment of multiple sclerosis Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients.Romidepsin targets multiple survival signaling pathways in malignant T cells Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Hairy cell leukemia: short review, today's recommendations and outlook.Recent advances in the treatment of multiple sclerosis.Should there be a standard therapy for mantle cell lymphoma?Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study.Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia.

P2860

Q28083080-E56029DF-A332-4894-947D-7C5EC9B32089 Q28263993-0DB6FFD2-2AF0-4A0B-BB34-F4DC317D1369 Q30452448-37C3B54C-1CBE-44B9-8B17-931F9BFC4FC2 Q34560328-471B4651-7F96-4293-A043-4D6112BA0A63 Q35016421-8C19CBD4-B45E-44A9-BA56-F4C47B9AC3CD Q35557390-675110F6-1661-44B2-8861-13F2DC5C96EE Q35691048-9E6CEF30-D2C0-4188-B917-16EF74F74292 Q36208306-5C7D520F-AE61-46DF-8754-5790983A7D5E Q36254237-543174B1-3C53-495D-84C0-126B09D81225 Q36768594-CB918E24-E61A-4D4C-9706-F4364E19A7A1 Q37621357-9A348F3A-11AA-41AD-8F17-5FA45C2E4320 Q38836048-B5881279-BF0E-4EF4-AF2E-162A0B5FD922 Q39779748-96E96CC3-6378-4411-B248-740E71AC570E Q48225965-E95D0744-6770-4267-8807-E2F92C39CF6F Q48233351-CC9F02DF-C827-4CF4-9A0D-ACEC8CFB1526

P2860

Cladribine: not just another purine analogue?

http://www.wikidata.org/entity/Q34992373

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Cladribine: not just another purine analogue?

@ast

Cladribine: not just another purine analogue?

@en

Cladribine: not just another purine analogue?

@nl

type

label

Cladribine: not just another purine analogue?

@ast

Cladribine: not just another purine analogue?

@en

Cladribine: not just another purine analogue?

@nl

prefLabel

Cladribine: not just another purine analogue?

@ast

Cladribine: not just another purine analogue?

@en

Cladribine: not just another purine analogue?

@nl

P1433

Q34992373-8A2EAC7B-8F75-4D0D-8801-17AAE4F0C7EF

P1476

Q34992373-1159F85D-31E2-4349-962E-7A296BD9336D

P2093

Q34992373-2E601756-148C-4A76-AB4E-993CBB654BCD

Q34992373-54425929-D246-460A-826C-1059929C0C8F

Q34992373-B2EA44F4-DBC4-42BB-B30D-82F5196A4F73

Q34992373-BAF1EFEE-1A1B-48EF-8F95-EDBA5ABB37B0

P2860

Q34992373-0573B849-C831-4187-8906-EC95DE9A40A4

Q34992373-0625D5FF-6580-4ECD-AA63-783E8564A475

Q34992373-16956405-BE2A-40D3-982C-A2ED5F248AB4

Q34992373-16C871C2-1B52-4F52-9A06-821A398ED400

Q34992373-1B5B5612-9876-4999-AD31-CA04DBD3AF42

Q34992373-1B76CC48-CEA3-4056-8227-7FB3307F7A73

Q34992373-2866C968-A529-444E-B284-361C4519B9B2

Q34992373-2F332383-3617-4DE4-8148-CBEE768952FA

Q34992373-32C7E08B-744E-4B32-AEC4-9EF81476C5E7

Q34992373-330CCC08-AD2E-4AA0-8AE7-EAAC727A7AF9

P304

Q34992373-E4823BDC-AA6D-4C20-8345-72E2A8EFCD62

P31

Q34992373-5D6628BB-959A-4C9C-8783-3B694E28E4FF

P356

Q34992373-0BCAA8DA-773E-4B6D-B17C-037664471AFA

P407

Q34992373-0EECA84F-9AA1-49DB-A389-FF8E8C7E08A4

P433

Q34992373-B286515D-3AFF-4A42-8686-A31942A4035C

P478

Q34992373-CCF3CD5E-248D-4AC0-9317-099CFA66A525

P577

Q34992373-E76B3A95-D7C9-4819-B9B3-9FC4E7CA5192

P698

Q34992373-67D7A767-2457-44B2-B50A-AE97299A5CE2

P356

13543780903071038

P1433

Expert Opinion on Investigational Drugs

P1476

Cladribine: not just another purine analogue?

@en

P2093

Elliot M Epner

http://www.w3.org/2001/XMLSchema#string

John D Phillips

http://www.w3.org/2001/XMLSchema#string

Margaret Yu

http://www.w3.org/2001/XMLSchema#string

Stephen Spurgeon

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway

Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.

Cladribine in the treatment of chronic lymphocytic leukemia.

P304

1169-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903071038

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19604118

http://www.w3.org/2001/XMLSchema#string